Marketing and sales solutions (MASS) is an independent management consultancy, dedicated to ensuring our clients achieve high performance through strategic brand development and implementation excellence. Focused on the pharmaceutical and health-care industries, our objective is to add straight to your bottom line. MASS has two primary areas of focus: Strategic Consulting and Implementation Excellence.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Press Releases | July 1, 2015 | Inizio
Pegasus shortlisted for three Communiqué awards and hopes to defend its Communications Consultancy of the Year win from 2014
Press Releases | June 22, 2015 | Health Unlimited
Over the last five years, Health Unlimited agencies have been shortlisted nearly 40 times, picking up a total of eight Communiqué Awards, which recognise the very best in healthcare communications.
White Papers and Resources | June 15, 2015 | Blue Latitude Health
Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30,000 delegates together to talk about innovations...
White Papers and Resources | June 1, 2015 | Anthill Agency
We are excited to reveal the names of the expert speakers at Anthill's next webinar "The right e-detailing content for rich data" on the 3rd June 2015, 3 PM GMT+2.
White Papers and Resources | May 29, 2015 | Blue Latitude Health
Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment...
White Papers and Resources | May 26, 2015 | Anthill Agency
Data is the fuel for your digital communication – powering you to not only learn about your customers but communicate more effectively too.
White Papers and Resources | May 21, 2015 | Blue Latitude Health
Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that...
White Papers and Resources | May 21, 2015 | Blue Latitude Health
In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.
White Papers and Resources | May 19, 2015 | Inizio
An overview of the PsO biologic and systemic patientOur PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot...
White Papers and Resources | May 19, 2015 | Inizio
An overview of the prostate cancer patientDownload our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by...